Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Multiple Myeloma 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Burkitt Lymphoma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Lymphoma, Mantle-Cell 4Leukemia 4Vomiting 3Neoplasms 3Nausea 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Breast Neoplasms 3Blast Crisis 3Smoldering Multiple Myeloma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Surveys and Questionnaires 4Dexamethasone 2Calcium Dobesilate 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Sugars 1Respiratory Therapy 1Oxygen 1Lisinopril 1Fentanyl 1Buspirone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Dyspnea × dexamethasone 21-phosphate × Clear all
NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡